학술논문
7. Neoadjuvant folfiri + bevacizumab in patients with resectable liver metastases from colo-rectal cancer: Results from a phase 2 trial and comparative analysis of early PET/CT scan vs RECIST criteria in predicting outcome.
Document Type
Article
Author
Source
European Journal of Surgical Oncology; Sep2016, Vol. 42 Issue 9, pS68-S68, 1p
Subject
Language
ISSN
07487983